CHD

Business Context and Reporting Period

Company: Church & Dwight Co., Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2006
Business Overview: The Company operates in three reportable segments: Consumer Domestic (household and personal care), Consumer International (primarily personal care), and Specialty Products Division (SPD). Key brands include ARM & HAMMER, Trojan, and ELEXA. The Company recently acquired the SPINBRUSH toothbrush business and a small skin care business in late 2005.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 5.2% ($21.7 million) driven by the SPINBRUSH acquisition ($12.3 million contribution) and price increases effective February 1, 2006. This was partially offset by unfavorable foreign exchange rates ($1.5 million).
• Expense Increases: Selling, general, and administrative (SG&A) expenses rose 14.3% ($7.9 million). Key drivers included:
  • $1.8 million stock-based compensation charge due to the adoption of SFAS No. 123R.
  • $1.8 million impairment charge on a Consumer International skin care tradename.
  • $2.1 million increase in legal professional fees.
• Profitability: Net income increased 5.9% despite higher expenses, aided by lower marketing spend ($4.3 million decrease) and contributions from new acquisitions.
• Cash Flow: Operating cash flow decreased significantly by $17.6 million to $13.6 million, primarily due to a $23.8 million increase in inventory (stockpiling for SPINBRUSH and ELEXA) and a $28.5 million decrease in accounts payable.

Guidance, Outlook, and Risks

• Price Increases: The Company implemented price increases of 4% to over 10% on approximately 35% of its U.S. consumer portfolio. Management expects the full benefit of these increases to be realized in the second quarter of 2006.
• Acquisition Integration: The Company assumed full responsibility for SPINBRUSH sales and operations in the U.S., Canada, and the U.K. effective April 1, 2006. Gross sales and expenses for this business will be fully consolidated in Q2.
• Cost Pressures: The Company faces rising costs for oil-based raw materials and packaging. Management is implementing cost reduction programs in formulation, packaging, and logistics.
• Legal Contingency: A $9.8 million reserve has been recorded regarding a pending appeal of a jury verdict in a distribution rights dispute in Mexico. The Company intends to pursue the appeal vigorously.
• Regulatory Risk: The FDA has issued draft guidance regarding the labeling of condoms containing nonoxynol-9 (N-9). While the Company believes its current labeling is compliant, future restrictions could impact sales or incur costs for obsolete inventory.
• Credit Covenants: The Company remains in compliance with its credit facility. The leverage ratio (Total Debt to Adjusted EBITDA) was 2.50 (limit 4.25) and the interest coverage ratio was 6.66 (minimum 3.0) for the trailing twelve months.

Investor Verification Checklist

• Q2 Margin Realization: Verify if the anticipated margin improvements from price increases materialize in the second quarter, considering potential consumer demand elasticity.
• Inventory Levels: Monitor inventory turnover and working capital trends to ensure the $23.8 million inventory build-up does not lead to future write-downs or cash flow constraints.
• Legal Outcome: Track the status of the Mexico distribution rights appeal to determine if the $9.8 million reserve will be released or if additional costs arise.
• SPINBRUSH Integration: Assess the full-year financial impact of the SPINBRUSH acquisition once fully consolidated in Q2.
• Commodity Costs: Evaluate the effectiveness of cost-reduction programs in offsetting rising oil-based raw material costs.